Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

677
Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
677

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Burden and economic impact of RSV hospitalisations among English adults, 2023/24.

The Journal of infection·2026
Same author

Regional Nasal Drug Deposition in Pediatric vs. Adult Models: In vitro Insights into User Technique and Breathing Patterns Sensitivity.

Pharmaceutical research·2026
Same author

Strategies to improve nasal administration of antiretroviral therapeutics for the treatment of NeuroAIDS.

Therapeutic delivery·2026
Same author

Bayesian optimization and machine learning for vaccine formulation development.

PloS one·2025
Same author

Formulation Development of a COVID-19 Recombinant Spike Protein-Based Vaccine.

Vaccines·2024
Same author

Determination of Deamidation in Adjuvanted Vaccine Antigens through Isoaspartic Acid Quantification.

Vaccines·2024

Related Experiment Video

Updated: Aug 16, 2025

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

1.8K

In Vitro Comparison of Local Nasal Vaccine Delivery and Correlation with Device Spray Performance.

Lillian Li1, John V Wilkins2, Amir R Esmaeili2

  • 1Vaccine CMC Development & Supply, Sanofi, Toronto, Room 121, Building 95, Sanofi, 1755 Steeles Avenue West, Toronto, ON, M2R 3T4, USA. lillian.li@Sanofi.com.

Pharmaceutical Research
|December 19, 2022
PubMed
Summary

This study evaluated intranasal vaccine delivery devices for infants, finding they consistently achieved over 80% delivery efficiency to nasal airways. Spray characteristics and nozzle distance significantly impacted vaccine deposition in infant nasal models.

Keywords:
infant nasal modelintranasal deviceregional depositionspray performancevaccine delivery efficiency

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K
Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

11.0K

Related Experiment Videos

Last Updated: Aug 16, 2025

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

1.8K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K
Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

11.0K

Area of Science:

  • Pharmaceutical Sciences
  • Biomedical Engineering
  • Pediatric Medicine

Background:

  • Intranasal vaccine delivery offers a needle-free alternative for infants.
  • Optimizing intranasal device performance is crucial for effective pediatric vaccination.
  • Understanding deposition patterns in infant nasal airways is essential for vaccine efficacy.

Purpose of the Study:

  • To investigate the correlation between spray characteristics and local deposition efficiency of a vaccine candidate in infant nasal airways.
  • To evaluate the performance of various intranasal delivery devices in a pediatric context.
  • To establish the first in vitro investigation of vaccine delivery in infants under 24 months.

Main Methods:

  • Developed in vitro tests to measure spray characteristics of four intranasal devices.
  • Assessed regional delivery of a vaccine formulation in five infant nasal airway replicas (3-24 months).
  • Correlated spray performance, geometric parameters, and delivery efficiency.

Main Results:

  • All four devices demonstrated consistent spray characteristics and high delivery efficiency (>80%) to target areas.
  • Delivery efficiency was influenced by droplet size distribution and nozzle tip-to-nasal valve distance.
  • Established correlations between spray performance and in vitro local dose deposition.

Conclusions:

  • Infant nasal models complement device spray performance evaluation.
  • In vitro infant nasal models can aid new product development by estimating delivery efficiency.
  • These findings facilitate the development of effective intranasal vaccine delivery systems for infants.